Feature

July 29, 2026

Medical Oddities: Tattoo Regret Meets Nanotech

This week is about smart tattoos, social clues, pool perks, and tea's surprising brain connection.

Conexiant

July 24, 2026

AACR Cancer Disparities Progress Report: Trends Show Mortality Rates Improve But Inequity in Care Remains

The American Association for Cancer Research (AACR) released its Cancer Disparities Progress Report 2026, featuring updates on the unprecedented progress against cancer. At the same time, the report n...

The ASCO Post

July 24, 2026

AACR Cancer Disparities Progress Report: Trends Show Mortality Rates Improve But Inequity in Care Remains

The ASCO Post

July 22, 2026

Medical Oddities: When AI Meets the Afterlife

Ghosts, germs, B cells, and brews—this week's research is anything but ordinary.

Conexiant

July 22, 2026

Early Research Examines Daraxonrasib in NRAS-Mutant Melanoma

Preclinical research showed antiproliferative activity against NRAS-mutant melanoma cell lines and antitumor activity against preclinical melanoma models.

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

July 22, 2026

Early Research Examines Daraxonrasib in NRAS-Mutant Melanoma

Preclinical research showed antiproliferative activity against NRAS-mutant melanoma cell lines and antitumor activity against preclinical melanoma models.

The ASCO Post

July 17, 2026

Tumor Microenvironment Ecotypes May Explain Differences in Multiple Myeloma Outcomes

“Our delineation of five distinct tumor microenvironment ecotypes in the bone marrows of patients with plasma cell disorders provides a new framework to understand the critical role of the host immune...

The ASCO Post

July 16, 2026

Digital Check-ins May Improve Outcomes in Patients Undergoing Treatment for Advanced Cancer

Researchers found that the biggest improvements were seen among patient groups that have historically faced the greatest barriers to care, including Black patients and individuals with less formal edu...

The ASCO Post

July 14, 2026

Adjuvant Selpercatinib Deemed ‘Immediately Practice-Changing’ in Early-Stage RET Fusion–Positive NSCLC

The phase III LIBRETTO-432 trial of adjuvant therapy with the central nervous system (CNS)–penetrant oral RET inhibitor selpercatinib met its primary endpoint of improved event-free survival in patien...

The ASCO Post

July 14, 2026

Aumolertinib Plus Chemotherapy in EGFR-Mutated Advanced NSCLC

In a Chinese phase III trial (AENEAS2) reported in The Lancet Oncology, Li et al found that the combination of aumolertinib with chemotherapy significantly improved progression-free survival vs aumole...

The ASCO Post

FDA Approves Ophthalmic Bevacizumab

Feature

Medical Oddities: Tattoo Regret Meets Nanotech

AACR Cancer Disparities Progress Report: Trends Show Mortality Rates Improve But Inequity in Care Remains

AACR Cancer Disparities Progress Report: Trends Show Mortality Rates Improve But Inequity in Care Remains

Medical Oddities: When AI Meets the Afterlife

Early Research Examines Daraxonrasib in NRAS-Mutant Melanoma

Daily News

Early Research Examines Daraxonrasib in NRAS-Mutant Melanoma

Tumor Microenvironment Ecotypes May Explain Differences in Multiple Myeloma Outcomes

Digital Check-ins May Improve Outcomes in Patients Undergoing Treatment for Advanced Cancer

Adjuvant Selpercatinib Deemed ‘Immediately Practice-Changing’ in Early-Stage RET Fusion–Positive NSCLC

Aumolertinib Plus Chemotherapy in EGFR-Mutated Advanced NSCLC

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

FDA Approves Ophthalmic Bevacizumab

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dentistry

ADA News

CDE World

New Dentist News

Conexiant

AACE Endocrinology AI

Conexiant

GI & Hepatology News

The ASCO Post

JADPRO

JNCCN

JNCCN 360

ASCO AI in Oncology

Glaucoma Physician

Ophthalmology Management

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

The Pathologist

The Medicine Maker

The Analytical Scientist

Feature

Daily News

Recommendations